Boston Scientific’s stock price was down 15% midday on Feb. 4, despite the company posting strong quarterly revenue and profit. The medtech company has major operations in Minnesota.
Original Image Link
Source:www.startribune.com
Original Image Link
Source:www.startribune.com
Posted: 2026-02-04 11:49:00

















